Top Institutions in Ophthalmology
Leading academic ophthalmology centers with strong vitreoretinal surgery programs and clinical trial expertise in retinal diseases typically conduct phase 3 trials and translational research on novel intravitreal therapies. Institutions with dedicated retina subspecialty divisions and experience in PVR management and drug development are recognized leaders.
-
#1
Oregon Health and Science University (Casey Eye Institute)
Portland, OR
Home to the Casey Eye Institute, OHSU is a leader in retinal disease research and clinical trials, including the GUARD trial investigating ADX-2191 for PVR surgery. Their expertise in vitreoretinal surgery and translational research supports innovation in intravitreal therapies.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for its vitreoretinal surgery expertise and leadership in clinical trials for retinal diseases, including PVR. Their robust research infrastructure supports evaluation of novel intravitreal drug formulations.
-
#3
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear is a leading center for retinal disease research and innovation in drug delivery systems for the eye. Their translational research bridges laboratory discoveries with clinical application in vitreoretinal disorders.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its clinical and research programs in retinal diseases, including proliferative vitreoretinopathy. Their clinical trials unit frequently evaluates new intravitreal agents and surgical adjuncts.